Amedisys Inc. Stock
Amedisys Inc. Stock
The price for the Amedisys Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.600%).
With 13 Buy predictions and not the single Sell prediction the community is currently very high on Amedisys Inc..
With a target price of 92 € there is a slightly positive potential of 10.18% for Amedisys Inc. compared to the current price of 83.5 €.
Pros and Cons of Amedisys Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amedisys Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amedisys Inc. | -0.600% | 0.000% | 0.000% | 21.014% | -1.183% | -64.316% | -25.004% |
| Amn Healthcare Svs | -0.950% | -0.952% | -7.965% | -32.903% | -22.388% | -20.611% | 16.749% |
| Ensign Group Inc. | -1.800% | -1.786% | -3.509% | - | 6.796% | - | - |
| Chemed Corp. | -0.880% | 1.802% | -5.833% | 10.784% | 8.654% | 48.684% | 93.427% |
Comments
Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) had its price target raised by analysts at Royal Bank of Canada from $97.00 to $100.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat
Amedisys, Inc. (NASDAQ: AMED) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for AMED provided by MarketBeat